BioNTech stock lost 2.2% and closed at 117.14. Pfizer shares reversed from an ... The company is testing the active ingredients found in mushrooms and ayahuasca to treat depression and anxiety ...

Lonza plans to exit its capsules and health ingredients business to concentrate on contract ... The rise of mRNA and recombinant protein vaccines (e.g., COVID-19 vaccines from Pfizer-BioNTech and ...

These innovations allow for the development of medications tailored to the unique needs of individual patients, enabling precise dosages and customized combinations of active ingredients ... In 2021, ...

As part of a global web of patent litigation over COVID-19 vaccines and mRNA technology, Pfizer and its partner BioNTech ...

A German court found Wednesday that American pharmaceutical giant Pfizer and German firm BioNTech violated a patent to make ...

A German court on Wednesday ruled that Pfizer and its partner BioNTech violated a COVID-19 vaccine patent held by Moderna .

Influenza causes 140,000 to 710,000 hospitalisations and 12,000 to 52,000 deaths in the US every year, as well as economic losses of around $25 billion a year, according to Pfizer.

Pfizer and BioNTech have been among the leaders in the race to bring a combined COVID-19 and influenza vaccine to market, but have stumbled in the final straight. The companies reported mixed ...

The post claims that Pfizer just released a list of side effects of its COVID-19 vaccine. It then proceeds to enumerate over 40 alleged side effects, including heart failure, liver damage ...

Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. The New York pharma is ending global development and commercialization of ...

The global Active Pharmaceutical Ingredients Market is expected to grow at 6.8% CAGR from 2025 to 2032. The latest Research report published by CMI with the title "An Increase in Demand and ...